Search Count: 26
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, RYW |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2021-04-07 Classification: APOPTOSIS Ligands: SO4, TUZ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2021-04-07 Classification: APOPTOSIS Ligands: SO4, TV5 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2021-04-07 Classification: APOPTOSIS Ligands: DMS, EDO, SO4, TUW |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2021-04-07 Classification: APOPTOSIS Ligands: TVH |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2021-04-07 Classification: APOPTOSIS Ligands: DMS, EDO, SO4, TVK |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2021-04-07 Classification: APOPTOSIS Ligands: EDO, U3Z |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.63 Å Release Date: 2018-08-22 Classification: APOPTOSIS Ligands: ZN, FUK |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2018-08-22 Classification: APOPTOSIS Ligands: ZN, NA, FUE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2018-06-27 Classification: APOPTOSIS Ligands: ZN, NA, A4E |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQT |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQW |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERZ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EU2 |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQZ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESQ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ER8 |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERW |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERK |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESK |